| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Revenue | $15.85B | -1.2% |
| Cost of Revenue | $10.39B | -5.4% |
| Gross Profit | $5.46B | +7.9% |
| R&D Expense | $621.0M | +4.7% |
| SG&A Expense | $1.73B | +3.7% |
| Operating Income | $2.80B | +21.4% |
| Pre-tax Income | $2.80B | +23.3% |
| Income Tax | -$397.0M | -209.1% |
| Net Income | $3.19B |
| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.32B | -20.6% |
| Accounts Receivable | $3.06B | +3.0% |
| Inventory | $2.52B | -1.4% |
| Current Assets | $7.63B | -3.3% |
| Total Assets | $22.85B | +5.3% |
| Current Liabilities | $4.75B | +6.3% |
| Long-term Debt | $3.33B | -5.6% |
| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.48B | +11.0% |
| Capital Expenditures | $680.0M | -7.1% |
| Investing Cash Flow | -$950.0M | -23.7% |
| Financing Cash Flow | -$2.87B | -60.0% |
| Free Cash Flow | $2.80B | +16.5% |
| +67.2% |
| EPS (Basic) | $10.40 | +71.6% |
| EPS (Diluted) | $10.33 | +71.3% |
| Total Liabilities |
| $10.37B |
| +3.1% |
| Stockholders' Equity | $12.36B | +7.0% |